| [1] PubMed ID: | 30623419 |
| Disease Name: | Neuroblastoma |
| Sample: | NB tissues |
| Dysfunction Pattern: | Interaction[miR-653-5p/STAT2 pathway] |
| Validated Method: | qRT-PCR |
| Description: | Our study revealed that SNHG7 expression was markedly higher in NB tissues than that in nontumor tissues. Jointly, our findings elucidated SNHG7 facilitated NB progression through the miR-653-5p/STAT2 pathway, providing a novel therapeutic target and prognostic biomarker for this disease. |
| Causality: | Yes |
| Causal Description: | Functionally, the loss-of-function assays demonstrated that knockdown of SNHG7 inhibited cell proliferation, migration, invasion, and epithelial-mesenchymal transition in NB cells. |
| Clinical-realted Application: | Besides, upregulated SNHG7 was greatly correlated with poor overall survival of NB patients. |
| [2] PubMed ID: | 32534305 |
| Disease Name: | Neuroblastoma |
| Sample: | NB tissues and cell lines |
| Dysfunction Pattern: | interaction[sponging miR-323a-5p and miR-342-5p] |
| Validated Method: | qRT-PCR//Luciferase Report Assay//RIP//Transwell Assay |
| Description: | We found that SNHG7 was upregulated in NB tissues and cell lines, and high SNHG7 level was relevant to poor prognosis of NB patients.In conclusion, our study suggested that SNHG7 silencing hindered NB progression at least partly though sponging miR-323a-5p and miR-342-5p, illuminating its potential value as a therapeutic target. |
| Causality: | Yes |
| Causal Description: | SNHG7 silencing resulted in the repression of NB cell migration, invasion and glycolysis. |
| Clinical-realted Application: | We found that SNHG7 was upregulated in NB tissues and cell lines, and high SNHG7 level was relevant to poor prognosis of NB patients. |
|